Machine learning-derived natural killer cell signature predicts prognosis and therapeutic response in clear cell renal cell carcinoma

Machine learning-derived natural killer cell signature predicts prognosis and therapeutic response in clear cell renal cell carcinoma

Background: Natural killer cells, interconnected with patient prognosis and treatment response, play a pivotal role in the tumor immune microenvironment and may serve as potential novel predictive biomarkers for renal cell carcinoma. Methods: Clear cell renal cell carcinoma transcriptome data and th...

Full description

Saved in:

Bibliographic Details
Main Authors:	Jinchen Luo, Mingjie Lin, Minyu Chen, Jinwei Chen, Xinwei Zhou, Kezhi Liu, Yanping Liang, Jiajie Chen, Hui Liang, Zhu Wang, Qiong Deng, Jieyan Wang, Meiyu Jin, Junhang Luo, Wei Chen, Junjie Cen
Format:	Article
Language:	English
Published:	Elsevier 2025-01-01
Series:	Translational Oncology
Subjects:	Single-cell RNA sequencing Clear cell renal cell carcinoma (CCRCC) Natural killer cell (NK cell) Prognosis Machine learning
Online Access:	http://www.sciencedirect.com/science/article/pii/S1936523324003061
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Natural killer cell memory: challenges and opportunities for cancer immunotherapy
by: Yuhua Qu, et al.
Published: (2024-12-01)

Emerging Insights into Memory Natural Killer Cells and Clinical Applications
by: Jonida Kokiçi, et al.
Published: (2024-11-01)

The elevated DERL3 expression indicates poor prognosis in renal clear-cell carcinoma
by: Weining Fan, et al.
Published: (2025-01-01)

The innate defenders: a review of natural killer cell immunotherapies in cancer
by: Pablo Álvarez-Carrasco, et al.
Published: (2024-12-01)

Trying to Kill a Killer; Impressive Killing of Patient Derived Glioblastoma Cultures Using NK-92 Natural Killer Cells Reveals Both Sensitive and Highly Resistant Glioblastoma Cells
by: Jane Yu, et al.
Published: (2025-01-01)

Natural killer cell biology and therapy in multiple myeloma: challenges and opportunities
by: Kamlesh Bisht, et al.
Published: (2024-11-01)

Syngeneic natural killer cell therapy activates dendritic and T cells in metastatic lungs and effectively treats low-burden metastases
by: Shih-Wen Huang, et al.
Published: (2025-01-01)

Expression pattern of cancer-associated cellular senescence genes in clear cell renal cell carcinoma distinguishes tumor subclasses with clinical implications
by: Zhongxu Zhu, et al.
Published: (2025-01-01)

Human NK cells and cancer
by: Claudia Cantoni, et al.
Published: (2024-12-01)

T-cell dysfunction in natural killer/T-cell lymphoma
by: Xiaoyan Feng, et al.
Published: (2023-12-01)

Natural killer cell in the development and treatment of head and neck squamous cell carcinoma
by: Lu-Ming WANG, et al.
Published: (2021-02-01)

Single-cell profiling aligns CD56bright and cytomegalovirus-induced adaptive natural killer cells to a naïve-memory relationship
by: M. Kazim Panjwani, et al.
Published: (2024-12-01)

An increase in regulatory T cells in peripheral blood correlates with an adverse prognosis for malignant melanoma patients – A study of T cells and natural killer cells
by: Nanna Heldager Pedersen, et al.
Published: (2024-01-01)

Mechanisms of Cbl-Mediated Ubiquitination of Proteins in T and Natural Killer Cells and Effects on Immune Cell Functions
by: Pulak Ranjan Nath, et al.
Published: (2024-12-01)

Advances in Induced Pluripotent Stem Cell-Derived Natural Killer Cell Therapy
by: Wenhua Qiao, et al.
Published: (2024-11-01)

Current landscape of clinical use of ex vivo expanded natural killer cells for cancer therapy
by: Júlia Teixeira Cottas de Azevedo, et al.
Published: (2024-12-01)

Prognostic significance of perioperative circulating CD56bright NK cell and recovery of NK cell activity in patients with colorectal cancer undergoing radical surgery
by: Jeng-Fu You, et al.
Published: (2025-02-01)

Low‐dose nivolumab for extranodal natural killer/T‐cell lymphoma, nasal type
by: Satish Maharaj, et al.
Published: (2024-12-01)

Combined immunotherapy with dendritic cells and cytokine-induced killer cells for solid tumors: a systematic review and meta-analysis of randomized controlled trials
by: Wendi Jiang, et al.
Published: (2024-12-01)

Impact of B7-H3 expression on metastasis, immune exhaustion and JAK/STAT and PI3K/AKT pathways in clear cell renal cell carcinoma
by: Maite Emaldi, et al.
Published: (2024-12-01)

Single-cell data revealed the function of natural killer cells and macrophage cells in chemotherapy tolerance in acute myeloid leukemia
by: Jing Gao, et al.
Published: (2024-11-01)

Application of adoptive cell therapy in malignant melanoma
by: Qianrong Hu, et al.
Published: (2025-01-01)

Revealing the role of natural killer cells in ankylosing spondylitis: identifying diagnostic biomarkers and therapeutic targets
by: Yuling Chen, et al.
Published: (2025-12-01)

Biological characteristics and immune responses of NK Cells in commonly used experimental mouse models
by: Jingwen Qin, et al.
Published: (2024-11-01)

CAR-NK cells derived from cord blood originate mainly from CD56−CD7+CD34−HLA-DR−Lin− NK progenitor cells
by: Tansri Wibowo, et al.
Published: (2024-12-01)

Bladder Metastasis from Clear Cell Renal Cell Carcinoma: A Case Report
by: İlkin Hamid-Zada, et al.
Published: (2024-07-01)

Natural killer cell engagers for cancer immunotherapy
by: Shahryar Khoshtinat Nikkhoi, et al.
Published: (2025-01-01)

Potential treatment approaches for malignant peritoneal mesothelioma: in vivo and in vitro experimental study of natural killer cell immunotherapy
by: Heliang Wu, et al.
Published: (2024-11-01)

Antitumor effects of natural killer cells derived from gene-engineered human-induced pluripotent stem cells on hepatocellular carcinoma
by: Mayuna Nakamura, et al.
Published: (2025-02-01)

Comparative Analysis of the Clinical Manifestations of Sinonasal Natural Killer T-Cell Lymphoma and Diffuse Large B-Cell Lymphoma
by: Chol Ho Shin, et al.
Published: (2024-07-01)

Clinical significance and pro-oncogenic function of DBF4 in clear cell renal cell carcinoma
by: Liuyan Chen, et al.
Published: (2025-01-01)

Predictive nomogram for ischemic stroke risk in clear cell renal cell carcinoma patients
by: Jie Wen, et al.
Published: (2024-12-01)

Alloimmune Causes of Recurrent Pregnancy Loss: Cellular Mechanisms and Overview of Therapeutic Approaches
by: Cristina Uța, et al.
Published: (2024-11-01)

Clinical features and prognosis of chronic natural killer cell lymphoproliferative disorders
by: Dong-lin Liu, et al.
Published: (2024-12-01)

Accumulation of tissue-resident natural killer cells, innate lymphoid cells, and CD8+ T cells towards the center of human lung tumors
by: Demi Brownlie, et al.
Published: (2023-12-01)

Tumor-initiating and metastasis-initiating cells of clear-cell renal cell carcinoma
by: Dinh-Xuan Pham, et al.
Published: (2025-02-01)

Kir6.1, a component of an ATP-sensitive potassium channel, regulates natural killer cell development
by: Natalie Samper, et al.
Published: (2024-12-01)

Nonlinear relationship between circulating natural killer cell count and 1-year relapse rates in myasthenia gravis: a retrospective cohort study
by: Yifan Zhang, et al.
Published: (2024-12-01)

Clinical Manifestations, Prognostic Factors, and Outcomes of Extranodal Natural Killer T-Cell Lymphoma: A Single-Center Experience in Thailand
by: Wasinee Kaewboot, et al.
Published: (2024-11-01)

FOXP3 as a prognostic marker and therapeutic target in immunogenic cell death modulation for clear cell renal cell carcinoma
by: Jian Chen, et al.
Published: (2025-01-01)